002907 華森製藥
按盤價 
14.810 -0.150 (-1.003%)
14.810 -0.150 (-1.003%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 4.327 | 4.682 | 2.026 | 6.842 | 7.499 |
| 總資產報酬率 ROA (%) | 3.701 | 4.072 | 1.759 | 5.409 | 5.255 |
| 投入資產回報率 ROIC (%) | 4.239 | 4.657 | 2.017 | 6.269 | 6.154 | 邊際利潤分析 |
| 銷售毛利率 (%) | 58.220 | 57.274 | 54.978 | 59.335 | 52.735 |
| 營業利潤率 (%) | 16.935 | 12.106 | 6.626 | 13.860 | 12.210 |
| 息稅前利潤/營業總收入 (%) | 13.326 | 10.664 | 4.916 | 14.161 | 12.441 |
| 淨利潤/營業總收入 (%) | 10.851 | 9.903 | 4.728 | 12.532 | 10.847 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 76.035 | 80.253 | 84.081 | 91.697 | 90.159 |
| 價值變動淨收益/利潤總額(%) | 20.170 | 1.474 | -10.910 | -2.407 | -1.283 |
| 營業外收支淨額/利潤總額(%) | -18.370 | -0.384 | -7.071 | -0.544 | 0.104 | 償債能力分析 |
| 流動比率 (X) | 4.665 | 4.864 | 4.742 | 4.528 | 4.320 |
| 速動比率 (X) | 4.133 | 4.203 | 3.938 | 3.985 | 3.704 |
| 資產負債率 (%) | 14.400 | 13.431 | 12.613 | 13.729 | 28.539 |
| 帶息債務/全部投入資本 (%) | 0.265 | -2.047 | -2.368 | -2.329 | 13.681 |
| 股東權益/帶息債務 (%) | 36,477.904 | -4,851.382 | -4,206.132 | -4,275.219 | 608.029 |
| 股東權益/負債合計 (%) | 587.056 | 644.531 | 692.802 | 628.379 | 250.398 |
| 利息保障倍數 (X) | -13.595 | -7.638 | -3.865 | 37.741 | 57.040 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 82.428 | 79.963 | 100.525 | 87.211 | 70.350 |
| 存貨周轉天數 (天) | 136.402 | 158.660 | 154.033 | 136.536 | 110.723 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 31/12/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
